A novel angiotensin I-converting enzyme mutation (S333W) impairs N-domain enzymatic cleavage of the anti-fibrotic peptide, AcSDKP.
BACKGROUND: Angiotensin I-converting enzyme (ACE) has two functional N- and C-domain active centers that display differences in the metabolism of biologically-active peptides including the hemoregulatory tetrapeptide, Ac-SDKP, hydrolysed preferentially by the N domain active center. Elevated Ac-SDKP...
Main Authors: | Sergei M Danilov, Michael S Wade, Sylva L Schwager, Ross G Douglas, Andrew B Nesterovitch, Isolda A Popova, Kyle D Hogarth, Nakul Bhardwaj, David E Schwartz, Edward D Sturrock, Joe G N Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3913711?pdf=render |
Similar Items
-
AcSDKP regulates cell proliferation through the PI3KCA/Akt signaling pathway.
by: Ping Hu, et al.
Published: (2013-01-01) -
Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide – AcSDKP
by: Thierry Josiane, et al.
Published: (2005-09-01) -
The effects of angiotensin converting enzyme inhibitors (ACEI) on human N-acetylseryl-aspartyl-lysyl-proline (AcSDKP) levels : a systematic review
by: Mnguni, Ayanda Trevor
Published: (2016) -
Valeryl-L-carnitine (C5) and N-acetyl-Ser-Asp-Lys-Pro (AcSDKP) have the potential to promote pancreatic cancer development.
by: Teng, Yi-Min, et al.
Published: (2017) -
The tetrapeptide Ac-SDKP and angiotensin converting enzyme in tuberculous pericarditis and fibrosis
by: Ramasamy, Vinasha
Published: (2021)